Table 1 |
||||||
|
Models of arthritis |
||||||
|
Model |
Abbreviation |
Speciesa |
Feature |
IC |
T cell |
References |
|
|
||||||
|
Trigger-induced models |
||||||
|
Non-specific immune stimuli |
||||||
|
Adjuvant-induced arthritis |
AA |
Lewis rat |
Autoimmune |
- |
+ |
|
|
Oil-induced arthritis |
OIA |
DA rat |
Autoimmune |
- |
+ |
[3] |
|
Pristane-induced arthritis |
PIA |
DA rat |
Autoimmune |
- |
+ |
|
|
Cartilage directed autoimmunity |
||||||
|
Collagen-induced arthritis |
CIA |
DBA mouse |
CII AI |
+ |
+ |
|
|
Proteoglycan-induced arthritis |
PGIA |
Balb/c mouse |
PG AI |
+ |
+ |
|
|
Infectious agents/exogenous triggers |
||||||
|
Streptococcal cell wall arthritis |
SCW-A |
Lewis rat |
Persistent bacteria AI |
- |
+ |
[10] |
|
Flare |
SCW-F |
Mouse |
Th17 |
- |
+ |
[11] |
|
Antigen-induced arthritis |
AIA |
Rabbit, mouse |
Persistent antigen |
+ |
+ |
|
|
Flare |
AIA-F |
Mouse |
Th17 |
- |
+ |
[14] |
|
Transgenic spontaneous models |
||||||
|
HTLV-induced arthritis |
HTLV |
Mouse |
Viral tax antigen |
- |
+ |
[15] |
|
KRN arthritis |
KRN |
K/BxN mouse |
GPI AI |
+ |
+ |
|
|
SKG arthritis |
SKG |
Mouse |
ZAP-70 T cell defect |
- |
+ |
|
|
GP130 arthritis |
GP130 |
Mouse |
STAT3, T cell defect |
- |
+ |
|
|
TNF transgenic arthritis |
TNFtg |
Mouse |
TNF overexpression |
- |
- |
|
|
IL-1ra transgenic arthritis |
IL-1ra-/- |
Balb/c mouse |
Autoimmune T cells |
± |
+ |
[23] |
|
IL-1 transgenic arthritis |
IL-1tg |
Mouse |
IL-1 overexpression |
- |
- |
[22] |
|
Immune complex models |
||||||
|
Collagen type II |
CAIA |
DBA mouse |
Mouse CII antibody |
+ |
- |
|
|
KRN serum |
GPI |
Balb/c mouse |
Mouse GPI antibody |
+ |
- |
[31] |
|
Poly-L-lysine-lysozyme |
PLL-L |
DBA mouse |
Cationic antigen |
+ |
- |
[28] |
|
|
||||||
|
aMost commonly used. AI = autoimmune; CAIA = collagen antibody-induced arthritis; GPI = glucose-6-phosphate isomerase; IC = immune complexes as an early feature; PG = proteoglycan. |
||||||
|
Berg Arthritis Research & Therapy 2009 11:250 doi:10.1186/ar2803 |
||||||